What is the equivalent dose of escitalopram (Lexapro) for an adult patient taking 10 mg paroxetine (Paxil) with normal hepatic and renal function? | Rounds What is the equivalent dose of escitalopram (Lexapro) for an adult patient taking 10 mg paroxetine (Paxil) with normal hepatic and renal function? | Rounds
Loading...

What is the equivalent dose of escitalopram (Lexapro) for an adult patient taking 10 mg paroxetine (Paxil) with normal hepatic and renal function?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Escitalopram (Lexapro) Equivalent for Paroxetine (Paxil) 10 mg

An adult dose equivalence for switching from paroxetine 10 mg daily to escitalopram 5 mg daily is shown in a switching-dose table that lists paroxetine 40 mg as targeting escitalopram 20 mg. [1]

Dose Equivalence Calculation

  • Paroxetine 40 mg corresponds to escitalopram 20 mg in the provided switching-dose table. [1]
  • Therefore, paroxetine 10 mg corresponds to escitalopram 5 mg (linear proportion based on the same table mapping). [1]

Initiation Thresholds for Switching

  • For SSRI-to-SSRI switching without a required washout, cross-taper or sequential titration strategies are typically used based on interaction risk and withdrawal risk, with dose increments guided by switching resources. [2]

Monotherapy vs Combination Therapy During Switch

  • Antidepressant switching strategies include stopping the first antidepressant while starting the second at prescribed target doses. [2]
  • Cross-tapering strategies may involve overlapping therapy for a short interval using dose increments to reduce discontinuation risk. [2]

Common Pitfalls to Avoid

  • Abrupt changes between short half-life SSRIs can increase discontinuation risk. [2]
  • Paroxetine has greater discontinuation risk than longer half-life SSRIs, which supports slower, structured switching. [2]

Targets or Goals of Therapy

  • The switch target is to reach the established therapeutic dose of the receiving antidepressant using an antidepressant-specific conversion table. [1]

Clinical Safety Note

  • Hepatic and renal function normalization reduces dose-adjustment needs, but switching plans should still consider withdrawal history and concurrent interacting medications. [2]

Related Questions